IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Strides Arcolab to Up Production

7:30 AM MDT | May 11, 2009

Pharmaceutical firm Strides Arcolab (Bangalore) says it has begun supplying Oseltamivir capsules, the generic equivalent of Roche’s Tamiflu, to various countries for swine flu treatment. Strides Arcolab, one of few approved Oseltamivir manufacturers in India, plans to start producing more than 2 million doses/month in June, as there are only limited stocks currently available, the company says. Strides Arcolab manufactures Oseltamivir at its U.S. FDA-approved and WHO-prequalified facility at Bangalore. “We are particularly well equipped to handle...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa